David Olagnier

5.2k total citations
67 papers, 2.8k citations indexed

About

David Olagnier is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, David Olagnier has authored 67 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 26 papers in Molecular Biology and 15 papers in Infectious Diseases. Recurrent topics in David Olagnier's work include interferon and immune responses (21 papers), Immune Cell Function and Interaction (13 papers) and Viral Infections and Vectors (10 papers). David Olagnier is often cited by papers focused on interferon and immune responses (21 papers), Immune Cell Function and Interaction (13 papers) and Viral Infections and Vectors (10 papers). David Olagnier collaborates with scholars based in Denmark, United States and Canada. David Olagnier's co-authors include John Hiscott, Rongtuan Lin, Alessandra Zevini, Yiliu Liu, Julien van Grevenynghe, Alexandre Sze, Cindy Chiang, Bernard Pipy, Agnès Coste and Françoise Benoit‐Vical and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and PLoS ONE.

In The Last Decade

David Olagnier

65 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Olagnier Denmark 29 1.3k 984 714 548 488 67 2.8k
Tsung-Hsien Chang Taiwan 24 1.2k 0.9× 1.1k 1.1× 505 0.7× 291 0.5× 410 0.8× 87 2.6k
Shalini Sharma India 25 1.1k 0.8× 666 0.7× 490 0.7× 232 0.4× 896 1.8× 56 2.6k
Robert G. Ulrich United States 33 1.0k 0.8× 933 0.9× 822 1.2× 256 0.5× 357 0.7× 100 2.7k
Shih‐Chin Cheng Netherlands 23 1.4k 1.1× 860 0.9× 1.2k 1.6× 345 0.6× 939 1.9× 39 3.1k
Sheng‐Fan Wang Taiwan 29 460 0.4× 948 1.0× 940 1.3× 440 0.8× 486 1.0× 100 2.8k
Ok Sarah Shin South Korea 27 675 0.5× 558 0.6× 641 0.9× 310 0.6× 478 1.0× 80 2.1k
Meilin Jin China 29 736 0.6× 1.1k 1.1× 875 1.2× 481 0.9× 723 1.5× 113 2.8k
Mikhail A. Gavrilin United States 33 1.5k 1.1× 2.1k 2.2× 280 0.4× 199 0.4× 481 1.0× 71 3.7k
Ken Laing United Kingdom 25 360 0.3× 831 0.8× 891 1.2× 667 1.2× 729 1.5× 57 2.9k
Gobardhan Das India 35 1.7k 1.4× 1.0k 1.0× 1.0k 1.5× 260 0.5× 1.2k 2.4× 72 3.9k

Countries citing papers authored by David Olagnier

Since Specialization
Citations

This map shows the geographic impact of David Olagnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Olagnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Olagnier more than expected).

Fields of papers citing papers by David Olagnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Olagnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Olagnier. The network helps show where David Olagnier may publish in the future.

Co-authorship network of co-authors of David Olagnier

This figure shows the co-authorship network connecting the top 25 collaborators of David Olagnier. A scholar is included among the top collaborators of David Olagnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Olagnier. David Olagnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isnard, Stéphane, et al.. (2024). HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses. Communications Biology. 7(1). 1688–1688. 1 indexed citations
2.
Paludan, Søren R., Thomas Pradeu, Andreas Pichlmair, et al.. (2024). Early host defense against virus infections. Cell Reports. 43(12). 115070–115070. 1 indexed citations
3.
Isnard, Stéphane, et al.. (2023). Harnessing Autophagy to Overcome Antigen-Specific T-Cell Dysfunction: Implication for People Living with HIV-1. International Journal of Molecular Sciences. 24(13). 11018–11018. 2 indexed citations
4.
Zevini, Alessandra, Enrico Palermo, Daniele Di Carlo, et al.. (2022). Inhibition of Glycolysis Impairs Retinoic Acid-Inducible Gene I–Mediated Antiviral Responses in Primary Human Dendritic Cells. Frontiers in Cellular and Infection Microbiology. 12. 910864–910864. 11 indexed citations
5.
Dagenais-Lussier, Xavier, Daina Avizonis, Luc Choinière, et al.. (2021). Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells. Autophagy. 18(6). 1256–1273. 14 indexed citations
6.
Dagenais-Lussier, Xavier, et al.. (2021). Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1. Autophagy. 17(11). 3408–3423. 14 indexed citations
7.
Olagnier, David, et al.. (2020). Cannabinoid-Induced Immunomodulation during Viral Infections: A Focus on Mitochondria. Viruses. 12(8). 875–875. 13 indexed citations
8.
Thyrsted, Jacob, Julia Blay‐Cadanet, Ebbe Toftgaard Poulsen, et al.. (2020). SARS‐CoV‐2 evades immune detection in alveolar macrophages. EMBO Reports. 21(12). e51252–e51252. 57 indexed citations
9.
Olagnier, David & Trine H. Mogensen. (2020). The Covid-19 pandemic in Denmark: Big lessons from a small country. Cytokine & Growth Factor Reviews. 53. 10–12. 69 indexed citations
10.
Castiello, Luciano, Alessandra Zevini, Elisabetta Vulpis, et al.. (2019). An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation. Cancer Immunology Immunotherapy. 68(9). 1479–1492. 24 indexed citations
11.
Kamaliddin, Claire, Sem Ezinmègnon, David Olagnier, et al.. (2019). Changes in monocyte subsets are associated with clinical outcomes in severe malarial anaemia and cerebral malaria. Scientific Reports. 9(1). 17545–17545. 19 indexed citations
12.
Liu, Yiliu, David Olagnier, & Rongtuan Lin. (2017). Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity. Frontiers in Immunology. 7. 662–662. 107 indexed citations
13.
Gunderstofte, Camilla, Christian K. Holm, & David Olagnier. (2017). 2017 Keystone Symposia at the Fairmont Banff Springs: Exploring new concepts in innate immunity and interferon signaling at the haunted castle. Cytokine & Growth Factor Reviews. 35. 1–6. 1 indexed citations
14.
Zevini, Alessandra, David Olagnier, & John Hiscott. (2017). Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways. Trends in Immunology. 38(3). 194–205. 261 indexed citations
15.
Aubouy, Agnès, David Olagnier, Gwladys Bertin, et al.. (2015). Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria. Malaria Journal. 14(1). 358–358. 19 indexed citations
16.
17.
Qian, Feng, Martijn A. Langereis, David Olagnier, et al.. (2014). Coxsackievirus Cloverleaf RNA Containing a 5′ Triphosphate Triggers an Antiviral Response via RIG-I Activation. PLoS ONE. 9(4). e95927–e95927. 20 indexed citations
18.
Olagnier, David, Rose‐Anne Lavergne, Étienne Meunier, et al.. (2011). Nrf2, a PPARγ Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria. PLoS Pathogens. 7(9). e1002254–e1002254. 68 indexed citations
19.
Lefèvre, Lise, Amandine Galès, David Olagnier, et al.. (2010). PPARγ Ligands Switched High Fat Diet-Induced Macrophage M2b Polarization toward M2a Thereby Improving Intestinal Candida Elimination. PLoS ONE. 5(9). e12828–e12828. 74 indexed citations
20.
Olagnier, David, Antoine Berry, Marie-Denise Linas, et al.. (2007). Modifications of the chemical structure of terpenes in antiplasmodial and antifungal drug research. Bioorganic & Medicinal Chemistry Letters. 17(22). 6075–6078. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsung-Hsien Chang Breakdown of academic impact, for papers by Shalini Sharma Breakdown of academic impact, for papers by Robert G. Ulrich Breakdown of academic impact, for papers by Shih‐Chin Cheng Breakdown of academic impact, for papers by Sheng‐Fan Wang Breakdown of academic impact, for papers by Ok Sarah Shin Breakdown of academic impact, for papers by Meilin Jin Breakdown of academic impact, for papers by Mikhail A. Gavrilin Breakdown of academic impact, for papers by Ken Laing Breakdown of academic impact, for papers by Gobardhan Das
Rankless by CCL
2026